U.S. Obesity Rates Decline as Weight-Loss Drugs Gain Popularity

A recent survey suggests a link between the drop in obesity and the increased use of medications like Ozempic.

The U.S. obesity rate fell by about two percentage points between 2020 and 2023, according to recent data.
Semaglutide drugs, including Ozempic and Wegovy, are believed to play a key role in this decline by suppressing appetite.
Prescriptions for these weight-loss drugs surged significantly during the period of declining obesity rates.
The decline in obesity is more pronounced among college graduates, who are more likely to use these medications.
Despite their benefits, these drugs have sparked controversy over their use as an 'easy way out' compared to traditional weight loss methods.